Abstract
Hepatocellular carcinoma (HCC) is a major cause of cancer morbidity and mortality in many parts of the world, including Asia and sub-Saharan Africa, where there are upwards of 600,000 new cases each year. Over 80% of the burden of HCC is manifest in the economically developing world. Further, the median age of diagnosis and death from HCC is between 45 and 55 years of age in these regions. Since the occurrence of HCC is coincident with regions where aflatoxin exposure is high, efforts started in the 1960s to investigate this possible association. Aflatoxin biomarkers of internal and biologically effective dose have been integral to definitively establish the etiologic role of this toxin in human HCC. In two separate cohort studies, a strong multiplicative relationship between aflatoxin exposure and the hepatitis B virus for the development of HCC was found. Further, in recent years, research has demonstrated that aflatoxin exposure is also linked to the occurrence of a specific mutation in the p53 tumor suppressor gene. Thus, the development and application of molecular biomarkers reflecting events from exposure to manifestation of clinical disease has rapidly expanded our knowledge of the mechanisms of disease pathogenesis in HCC, and this will have increasing potential for early detection, treatment, interventions, and prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamson RH, Correa P, Sieber SM, McIntire KR, Dalgard DW. (1976). J Natl Cancer Inst 57:67–78
Aguilar F, Hussain SP, Cerutti P. (1993). Proc Natl Acad Sci USA 90:8586–90
Arbuthnot P, Kew M. (2001). Int J Exp Pathol 82:77–100
Asao T, Buchi G, Abdel-Kader M, Chang S, Wick E, Wogan GN. (1963). J Am Chem Soc 85:1706–7
Autrup H, Bradley KA, Shamsuddin AK, Wakhisi J, Wasunna A. (1983). Carcinogenesis 4:1193–5
Autrup H, Seremet T, Wakhisi J, Wasunna A. (1987). Cancer Res 47:3430–3
Bailey GS, Loveland PM, Pereira C, Pierce D, Hendricks JD, Groopman JD. (1994). Mutat Res 313:25–38
Bennett RA, Essigmann JM, Wogan GN. (1981). Cancer Res 41:650–4
Blount WP. (1961). J Br Turkey Fed 9:55–8
Bolton MG, Munoz A, Jacobson LP, Groopman JD, Maxuitenko YY, et al. (1993). Cancer Res 53:3499–504
Bressac B, Kew M, Wands J, Ozturk M. (1991). Nature 350:429–31
Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA. (1982). Int J Epidemiol 11:112–9
Busby WF, Wogan GN. (1984a). Aflatoxins. Washington, DC: American Chemical Society. pp. 945–1136
Busby WFJ, Wogan GN. (1984b). Aflatoxins. In Chemical Carcinogens, ed. CD Searle, pp. 945–1136. Washington, DC: American Chemical Society
Campbell TC, Caedo JP, Jr., Bulatao-Jayme J, Salamat L, Engel RW. (1970). Nature 227:403–4
Campbell AD, Whitaker TB, Pohland AE, Dickens JW, Park DL. (1986). Pure Appl Chem 58:305–14
Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, et al. (2006). Int J Cancer 119:1447–54
Croy RG, Wogan GN. (1981). J Natl Cancer Inst 66:761–7
Denissenko MF, Koudriakova TB, Smith L, O’Connor TR, Riggs AD, Pfeifer GP. (1998). Oncogene 17:3007–14
Eaton DL, Groopman JD. (1994). The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance. San Diego, CA: Academic Press
Egner PA, Gange SJ, Dolan PM, Groopman JD, Munoz A, Kensler TW. (1995). Carcinogenesis 16:1769–73
Egner PA, Groopman JD, Wang JS, Kensler TW, Friesen MD. (2006). Chem Res Toxicol 19:1191–5
Essigmann JM, Croy RG, Nadzan AM, Busby WF, Jr., Reinhold VN, et al. (1977). Proc Natl Acad Sci USA 74:1870–4
Ferlay J, Bray F, Pisani P, Parkin DM. (2004). GLOBOCAN 2002, Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5, version 2.0. Lyon: IARC
Foster PL, Eisenstadt E, Miller JH. (1983). Proc Natl Acad Sci USA 80:2695–8
Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, et al. (1988). Carcinogenesis 9:1323–5
Gopalan C, Tulpule PG, Krishnamurthi D. (1972). Food Cosmet Toxicol 10:519–21
Greenblatt MS, Bennett WP, Hollstein M, Harris CC. (1994). Cancer Res 54:4855–78
Groopman JD, Kensler TW. (2005). Toxicol Appl Pharmacol 206:131–7
Groopman JD, Trudel LJ, Donahue PR, Marshak-Rothstein A, Wogan GN. (1984). Proc Natl Acad Sci USA 81:7728–31
Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN. (1985). Proc Natl Acad Sci USA 82:6492–6
Groopman JD, DeMatos P, Egner PA, Love-Hunt A, Kensler TW. (1992a). Carcinogenesis 13:101–6
Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, et al. (1992b). Cancer Epidemiol Biomarkers Prev 1:221–7
Groopman JD, Hasler JA, Trudel LJ, Pikul A, Donahue PR, Wogan GN. (1992c). Cancer Res 52:267–74
Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, et al. (1992d). Cancer Res 52:45–52
Groopman JD, Kensler TW, Wild CP. (2008). Annu Rev Public Health 29:187–203
Harris CC. (1993). Multistep carcinogenesis. Jpn J Cancer Res 84:inside front cover
Harris CC. (1994). Cancer Epidemiol Biomarkers Prev 3:1–2
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. (1991). Nature 350:427–8
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. (2007). Oncogene 26:2166–76
IARC. (1993). Aflatoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer. Vol 56. Lyon: IARC. pp. 245–395
Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, et al. (2001). Cancer Res 61:33–5
Jackson PE, Kuang SY, Wang JB, Strickland PT, Munoz A, et al. (2003). Carcinogenesis 24:1657–63
Kensler TW, Egner PA, Trush MA, Bueding E, Groopman JD. (1985). Carcinogenesis 6:759–63
Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD. (1986). Cancer Res 46:3924–31
Kensler TW, Gange SJ, Egner PA, Dolan PM, Munoz A, et al. (1997). Cancer Epidemiol Biomarkers Prev 6:603–10
Kew MC. (2002). Toxicology 181–182:35–8
Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, et al. (2000). J Natl Cancer Inst 92:148–53
Lancaster MC, Jenkins FP, Philp JM. (1961). Nature 192:1095–6
Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, et al. (1997). Cancer Res 57:3471–7
Lutz WK. (1987). Arch Toxicol Suppl 11:66–74
McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, et al. (1995). Proc Natl Acad Sci USA 92:2384–7
Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, et al. (2002). Hepatology 36:1214–20
Nesbitt BF, O’Kelly J, Sargeant K, Sheridan A. (1962). Nature 195:1062–3
Parkin DM, Bray F, Ferlay J, Pisani P. (2005). CA Cancer J Clin 55:74–108
Peers FG, Linsell CA. (1977). Ann Nutr Aliment 31:1005–17
Poirier MC, Santella RM, Weston A. (2000). Carcinogenesis 21:353–9
Probst C, Njapau H, Cotty PJ. (2007). Appl Environ Microbiol 73:2762–4
Puisieux A, Lim S, Groopman J, Ozturk M. (1991). Cancer Res 51:6185–9
Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, et al. (1994). Cancer Epidemiol Biomarkers Prev 3:3–10
Richard JL, Bennett GA, Ross PF, Nelson PE. (1993). J Anim Sci 71:2563–74
Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW. (1991). Cancer Res 51:5501–6
Ross RK, Yuan JM, Yu MC, Qian GS, Tu JT, et al. (1992a). Lancet 339:943–6
Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, et al. (1992b). Lancet 339:943–6
Sabbioni G, Skipper PL, Buchi G, Tannenbaum SR. (1987). Carcinogenesis 8:819–24
Santella RM. (1999). Cancer Epidemiol Biomarkers Prev 8:733–9
Sargeant K, Sheridan A, O’Kelly J, Carnaghan RBA. (1961). Nature 192:1096–7
Scholl PF, Groopman JD. (2008). Cancer Epidemiol Biomarkers Prev 17:1436–9
Scholl PF, McCoy L, Kensler TW, Groopman JD. (2006a). Chem Res Toxicol 19:44–9
Scholl PF, Turner PC, Sutcliffe AE, Sylla A, Diallo MS, et al. (2006b). Cancer Epidemiol Biomarkers Prev 15:823–6
Sidransky D, Hollstein M. (1996). Annu Rev Med 47:285–301
Sieber SM, Correa P, Dalgard DW, Adamson RH. (1979). Cancer Res 39:4545–54
Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. (2002). Proc Natl Acad Sci USA 99:6655–60
Sun Z, Lu P, Gail MH, Pee D, Zhang Q, et al. (1999). Hepatology 30:379–83
Thorgeirsson SS, Grisham JW. (2002). Nat Genet 31:339–46
Thorgeirsson UP, Dalgard DW, Reeves J, Adamson RH. (1994). Regul Toxicol Pharmacol 19:130–51
Thorgeirsson SS, Lee JS, Grisham JW. (2006). Hepatology 43:S145–50
Tilak TB. (1975). Food Cosmet Toxicol 13:247–9
Van der Zijden ASM, Koelensmid WAAB, Boldingh J, Barrett CB, Ord WO, Philp J. (1962). Nature 195:1060–2
Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF. (1985). Br J Cancer 51:713–26
Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, et al. (1995). Cancer Epidemiol Biomarkers Prev 4:475–83
Wang JS, Groopman JD. (1998). Biomarkers for Carcinogen Exposure: Tumor Initiation. Washington, DC: Taylor & Francis. pp. 145–66
Wang JS, Qian GS, Zarba A, He X, Zhu YR, et al. (1996a). Cancer Epidemiol Biomarkers Prev 5:253–61
Wang LY, Hatch M, Chen CJ, Levin B, You SL, et al. (1996b). Int J Cancer 67:620–5
Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, et al. (2002). Toxicology 181–182:43–7
Wild CP, Turner PC. (2002). Mutagenesis 17:471–81
Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, et al. (1992). Cancer Epidemiol Biomarkers Prev 1:229–34
Williams DE, Orner G, Willard KD, Tilton S, Hendricks JD, et al. (2009). Comp Biochem Physiol C Toxicol Pharmacol 149:175–81
Wogan GN, Newberne PM. (1967). Cancer Res 27:2370–6
Yeh FS, Shen KN. (1986). Epidemiology and early diagnosis of primary liver cancer in China. Adv. Cancer Res. 47:297–329
Yeh FC, Chang CL, Liu WS. (1986). Ma Zui Xue Za Zhi 24:216–21
Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. (1989). Cancer Res 49:2506–9
Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. (1997). J Hepatol 27:320–30
Acknowledgments
This work was supported in part by grants P01 ES006052 and P30 ES003819 from the USPHS.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Groopman, J.D., Wogan, G.N. (2011). Aflatoxin and Hepatocellular Carcinoma. In: Penning, T. (eds) Chemical Carcinogenesis. Current Cancer Research. Humana Press. https://doi.org/10.1007/978-1-61737-995-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-61737-995-6_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61737-994-9
Online ISBN: 978-1-61737-995-6
eBook Packages: MedicineMedicine (R0)